What is the quickest way to formulate a levodopamine (levodopa) drip for a patient with hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Quickest Dopamine Drip Formulation

Use the "Rule of 6" method: multiply 0.6 × patient's weight in kg = number of milligrams of dopamine, then dilute to a total of 100 mL of saline; at this concentration, 1 mL/h delivers 0.1 mcg/kg/min. 1

Rapid Preparation Methods

Rule of 6 Method (Preferred for Pediatrics)

  • Calculation: 0.6 × body weight (kg) = mg of dopamine to add 2, 1
  • Dilute calculated dose to total 100 mL of saline 2, 1
  • Infusion rate: 1 mL/h = 0.1 mcg/kg/min 1
  • Example: For a 20 kg child: 0.6 × 20 = 12 mg dopamine in 100 mL saline 1

Standard Adult Concentration (Alternative)

  • Preparation: 400 mg dopamine in 500 mL of 5% dextrose 2
  • This creates a standard concentration for adult dosing 2
  • Requires individual calculation: Infusion rate (mL/h) = (Weight [kg] × Dose [mcg/kg/min] × 60 min/h) / Concentration (mcg/mL) 2

Dosing Guidelines

Initial Dosing

  • Start at 2-5 mcg/kg/min for most patients 1
  • Titrate to maintain systolic BP >90 mmHg (or age-appropriate target) 1
  • Therapeutic range: 2-20 mcg/kg/min 2, 1

Dose-Dependent Effects

  • 2-3 mcg/kg/min: Dopaminergic effects (renal/mesenteric vasodilation) 2, 1
  • 3-5 mcg/kg/min: β-adrenergic effects (increased cardiac contractility) 2, 1
  • >5-10 mcg/kg/min: α-adrenergic effects (peripheral vasoconstriction) 2, 1

Critical Safety Measures

Administration Requirements

  • Use large vein (antecubital fossa preferred over hand/ankle) to prevent extravasation 3
  • Continuous BP monitoring required, preferably with arterial line at higher doses 2, 1
  • Cover infusion container with protective foil to prevent light degradation 1

Extravasation Management

  • If extravasation occurs, inject phentolamine 0.1-0.2 mg/kg (up to 10 mg) diluted in 10 mL of 0.9% saline intradermally at the site 1
  • Monitor extremities for color/temperature changes indicating compromised circulation 3

When to Switch Agents

  • If doses approach >20 mcg/kg/min without adequate response, consider switching to norepinephrine 1
  • If tachycardia >100 bpm develops, consider alternative vasopressors 2, 1
  • Dopamine should be avoided in patients with tachyarrhythmias 4

Important Caveats

Drug Interactions

  • MAO inhibitor use: Reduce initial dopamine dose to 1/10 of usual dose if patient received MAO inhibitors within 2-3 weeks 3
  • Halogenated anesthetics: Use extreme caution due to risk of ventricular arrhythmias 3
  • β-blockers may require higher dopamine doses (up to 20 mcg/kg/min) to achieve effect 2

Pre-Administration Requirements

  • Correct hypovolemia first: Administer 1-2 L normal saline to adults (5-10 mL/kg in first 5 minutes) or up to 30 mL/kg in first hour for children 2
  • Correct hypoxia, hypercapnia, and acidosis before or during dopamine administration 3

Weaning Protocol

  • Gradually decrease by steps when discontinuing 2
  • Expand blood volume with IV fluids while tapering to prevent marked hypotension 3

Note on "Levodopamine": The evidence provided addresses dopamine (the vasopressor) exclusively. If the question refers to levodopa (the Parkinson's medication), this is contraindicated for hypotension as levodopa causes hypotension through negative inotropic effects 5, 6. Levodopa should never be used as a vasopressor.

References

Guideline

Dopamine Administration in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Norepinephrine Dosing for Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cardiovascular effects of levodopa in Parkinson's disease.

Parkinsonism & related disorders, 2014

Research

[Worsened orthostatic hypotension due to levodopa administration in a case of Parkinson's disease].

Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.